ETH-201

N/A

Report date: 2023/03/02 16:29:51
NME

Base Information

Drug NameETH-201
Drug Alias NameETH-201
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProprotein convertase subtilisin kexin type 9 inhibitors
TargetsProprotein convertase subtilisin kexin type 9
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShengke Pharmaceutical (Jiangsu) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShengke Pharmaceutical (Jiangsu) Co Ltd
Inactive CompaniesN/A
Active IndicationsCardiovascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A